Small cell lung cancer (Homo sapiens)
From WikiPathways
Description
Small cell lung carcinoma (SCLC) is a highly malignant cancer of the lung.
Genes altered in small cell lung carcinoma:
- TP53 is mutated in 70 to 90% of SCLCs.
- RB1 is inactivated in most SCLCs.
- PTEN is mutated in 2 to 10% of SCLCs.
- MYC amplifications and amplification of MYC family members are found in 30% of SCLCs.
- FHIT protein expression is lost due to Loss of heterozygocity (LOH) on chromosome arm 3p found in more than 80% of SCLCs.
Quality Tags
Ontology Terms
Bibliography
- Deng WG, Nishizaki M, Fang B, Roth JA, Ji L; ''Induction of apoptosis by tumor suppressor FHIT via death receptor signaling pathway in human lung cancer cells.''; Biochem Biophys Res Commun, 2007 PubMed Europe PMC Scholia
- Hornbeck PV, Zhang B, Murray B, Kornhauser JM, Latham V, Skrzypek E; ''PhosphoSitePlus, 2014: mutations, PTMs and recalibrations.''; Nucleic Acids Res, 2015 PubMed Europe PMC Scholia
- ''KEGG small cell lung cancer''; https://www.kegg.jp/dbget-bin/www_bget?pathway+map05222,
History
View all... |
External references
DataNodes
View all... |
Annotated Interactions
No annotated interactions